Human P450 Antibodies Portfolio

About CYP450-GP

CYP450-GP is a privately held, revenue-generating reagent supplier founded in 2015 and based in Vista (San Diego area), California. The company has developed a proprietary portfolio of highly specific inhibitory antibodies targeting key drug-metabolizing cytochrome P450 enzymes, which are used by pharmaceutical companies and research labs for critical early-stage drug development studies. Its core product, the CYP Immunoinhibition Kit, provides a standardized solution for reaction phenotyping, a regulatory requirement. With a lean operational model and deep expertise in P450 biology, the company serves a niche but essential segment of the drug development tools market.